UBLITUXIMAB Pharmacologic Class Indexing
- Class set ID
- 857f7174-181c-4ccd-99ca-4c469976a6b7
- Version
- 1
- Effective date
- 20231116
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
| Label | Manufacturer | Effective | SPL version |
|---|---|---|---|
| These highlights do not include all the information needed to use BRIUMVI safely and effectively. See full prescribing information for BRIUMVI. BRIUMVI ® (ublituximab-xiiy) injection, for intravenous use Initial U.S. Approval: 2022 | TG Therapeutics, Inc. | Packaging Coordinators, LLC | Samsung Biologics Co., Ltd. | Pharma Packaging Solutions, LLC | 20260219 | 21 |